Where Olema Pharmaceuticals Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Olema Pharmaceuticals (NASDAQ:OLMA) stock. The current average price target for the stock has increased by 21.74% from the previous average price target of $17.25 to $21.0. The analysts are generally bullish on the stock.
September 05, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts are generally bullish on Olema Pharmaceuticals, with an increased average price target of $21.0.
The bullish sentiment from analysts, coupled with an increased average price target, indicates a positive outlook for Olema Pharmaceuticals. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100